Google’s Vertex AI is a powerful platform that enables data scientists and developers to build, deploy, and scale machine ...

Vertex scored high marks across the core areas of the HDI Support Center Certification ... Introduced in 2000, the HDI ...

The VERTEX 80 and the VERTEX 80v standard configuration provides apodized spectral resolution that is better than 0.2 cm-1, which is adequate for most room temperature sample measurements and ...

Amidst the long-running Cas9 patent battle, Editas Medicine has struck a deal to sell a portion of its future revenue stream ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...

With some recent changes in the economy, interest in growth stocks is back on the rise. If you have available cash to invest, ...

Vertex Energy has filed for bankruptcy in a Texas court, just months after it paused renewable diesel output at an Alabama refinery over macroeconomic woes, the U.S. refiner said on Tuesday.

Discover Vertex Pharmaceuticals' groundbreaking patent for variant PD-1 polypeptides, enhancing immunomodulatory proteins for innovative cancer and immune therapies.

Kirkland & Ellis is serving as restructuring counsel, Bracewell LLP is serving as restructuring co-counsel, Perella Weinberg Partners is serving as the investment banker, and Alvarez & Marsal is ...

Construction delays, market share and renewable fuel programs: Here's what led Vertex Energy to file for bankruptcy protection.

Vertex stock is significantly undervalued due to the underestimated potential of its pain treatment drug, VX-548, which could become a blockbuster. VX-548 has shown to be more effective than ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.